Physician

Joseph Raevis

According to 2025 Medicare claims, Joseph Raevis (NPI: 1508253048) practices ophthalmology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is MONMOUTH RETINA CONSULTANTS, P.A. (NPI: 1437179942; TIN: 222485860) and primary practice location at 07739-1208. Raevis is affiliated with the Lahey Clinical Performance ACO (ACO ID: A1490), participating under the MSSP model.

Raevis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 738 traditional Medicare patients, billed 25,084 HCPCS/CPT codes, and received $1,880,997 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 429 prescription claims across 146 beneficiaries totaling $27,549 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 13 records totaling $367. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $15,483 to $1,880,997. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $625 and ending at $27,549. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$940K$1.9M2019 Medicare payment: $15,483 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $18,523 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $32,886 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $106,152 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $941,432 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,880,997 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019100195$15,483
2020150260$18,523
2021165393$32,886
20223171,543$106,152
202361513,830$941,432
202473825,084$1,880,997

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$14K$28K2015 Drug cost: $625 (USD; Tot_Drug_Cst)2016 Drug cost: $11,720 (USD; Tot_Drug_Cst)2017 Drug cost: $21,956 (USD; Tot_Drug_Cst)2018 Drug cost: $25,563 (USD; Tot_Drug_Cst)2019 Drug cost: $18,099 (USD; Tot_Drug_Cst)2020 Drug cost: $24,992 (USD; Tot_Drug_Cst)2021 Drug cost: $15,850 (USD; Tot_Drug_Cst)2022 Drug cost: $5,006 (USD; Tot_Drug_Cst)2023 Drug cost: $12,447 (USD; Tot_Drug_Cst)2024 Drug cost: $27,549 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R17$625
201632125$11,720
201751289$21,956
201890348$25,563
201998238$18,099
202088225$24,992
202157121$15,850
202231101$5,006
202384193$12,447
2024146429$27,549

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2721,128$102
92014Established patient complete exam of visual system448575$98
92012Established patient problem focused exam of visual system314574$67
92134Imaging of retina5131,297$32
92250Photography of the retina494581$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate563,174$3,650
Ketorolac TromethamineKetorolac Tromethamine532,602$1,794
Atropine SulfateAtropine Sulfate331,346$996
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha731,742$711
LatanoprostLatanoprost442,392$460

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.13$367Bausch & Lomb Americas Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Joseph Raevis?

Tedicare shows public-source Medicare data for Joseph Raevis (NPI 1508253048), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joseph Raevis have ACO affiliation data?

Joseph Raevis is shown with ACO affiliation data for Lahey Clinical Performance ACO (MSSP, ACO ID A1490).

What billing organization is linked to Joseph Raevis?

Joseph Raevis is linked to MONMOUTH RETINA CONSULTANTS, P.A. (billing NPI 1437179942) in the available physician profile data.

Does Joseph Raevis have Open Payments data?

Joseph Raevis has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.